caficrestat: Clinical Trials

1 trial of caficrestat, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Active not recruiting 1

Follow caficrestat: new trials by email Literature Review of caficrestat trials Research Report on caficrestat

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy
AT-001, Placebo - Diabetic Cardiomyopathies
Phase 3Active not recruitingApplied Therapeutics, Inc.6752019-09-202022-12-08

Conditions studied

Diabetes Mellitus, Type 2 (1)  ·  Diabetic Cardiomyopathies (1)

Sponsors

Applied Therapeutics, Inc. (1)

Countries

Australia (1)  ·  Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Poland (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

James L Januzzi, MD (1)

Results publications

PMID 38302936, PMID 38597864, PMID 38986667, PMID 39095808, PMID 39806375, PMID 39882614, PMID 40315802, PMID 40338768, PMID 42538062